This finding supports the use of EFEMP1 methylation for PCa detection in bodily fluids such as urine or serum/plasma (and which has not been tested in any of the studies) allowing for the discrimination from BCa and RCT, that were shown by us and others to be diagnosable in urine samples 15,26,27. Here, EFEMP1 is linked to posterior cortical atrophy.